
OrganiGram Holdings OGI
$ 1.06
-1.85%
Quarterly report 2024-Q3
added 05-06-2026
OrganiGram Holdings DIO Ratio 2011-2026 | OGI
Annual DIO Ratio OrganiGram Holdings
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | 2.83 K | - | - | - | - | - |
All numbers in CAD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.83 K | 2.83 K | 2.83 K |
DIO Ratio of other stocks in the Drug manufacturers industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Endo International plc
ENDP
|
100 | - | - | $ 28.9 M | ||
|
Evoke Pharma
EVOK
|
995 | - | - | $ 36.6 M | ||
|
Cumberland Pharmaceuticals
CPIX
|
280 | $ 5.6 | -1.23 % | $ 83.2 M | ||
|
HEXO Corp.
HEXO
|
703 | - | 2.45 % | $ 38.1 M | ||
|
AcelRx Pharmaceuticals
ACRX
|
30.8 | - | 7.5 % | $ 6.35 M | ||
|
DURECT Corporation
DRRX
|
557 | - | - | $ 50.1 M | ||
|
Adamis Pharmaceuticals Corporation
ADMP
|
48.9 | - | 0.86 % | $ 117 M | ||
|
Aerie Pharmaceuticals
AERI
|
459 | - | - | $ 754 M | ||
|
Agile Therapeutics
AGRX
|
82.7 | - | 10.11 % | $ 58.2 M | ||
|
Alimera Sciences
ALIM
|
58.7 | - | - | $ 142 M | ||
|
Cronos Group
CRON
|
221 | $ 2.68 | -2.55 % | $ 1.03 B | ||
|
Athenex
ATNX
|
158 | - | -23.39 % | $ 1.76 M | ||
|
Harrow Health
HROW
|
65.1 | $ 37.64 | -0.03 % | $ 1.38 B | ||
|
Avadel Pharmaceuticals plc
AVDL
|
366 | - | - | $ 2.06 B | ||
|
Catalent
CTLT
|
71.9 | - | - | $ 11.5 B | ||
|
Eagle Pharmaceuticals
EGRX
|
149 | - | -39.89 % | $ 27.7 M | ||
|
Canopy Growth Corporation
CGC
|
167 | $ 1.0 | -0.99 % | $ 108 M | ||
|
Organogenesis Holdings
ORGO
|
85.9 | $ 2.34 | -1.68 % | $ 297 M | ||
|
Pacira BioSciences
PCRX
|
246 | $ 22.99 | -1.58 % | $ 1.06 B | ||
|
Sonoma Pharmaceuticals
SNOA
|
117 | $ 1.09 | -0.91 % | $ 1.35 M | ||
|
Aurora Cannabis
ACB
|
1.35 K | $ 3.04 | -1.3 % | $ 167 M | ||
|
Jupiter Wellness
JUPW
|
80.2 | - | - | $ 33.6 M | ||
|
Lannett Company
LCI
|
127 | - | 1.15 % | $ 7.11 M | ||
|
Tilray
TLRY
|
170 | $ 4.98 | -2.73 % | $ 3.08 B | ||
|
cbdMD
YCBD
|
138 | $ 0.69 | -1.72 % | $ 2.78 M | ||
|
Evolus
EOLS
|
71.3 | $ 6.73 | 3.38 % | $ 434 M | ||
|
Emergent BioSolutions
EBS
|
367 | $ 8.32 | -0.83 % | $ 445 M | ||
|
Veru
VERU
|
179 | $ 3.0 | -7.98 % | $ 43.9 M | ||
|
Assertio Holdings
ASRT
|
322 | $ 23.48 | 0.04 % | $ 150 M | ||
|
ProPhase Labs
PRPH
|
74.8 | - | - | $ 5.07 M | ||
|
Radius Health
RDUS
|
204 | - | - | $ 1.42 B | ||
|
Bausch Health Companies
BHC
|
172 | $ 5.06 | -1.94 % | $ 1.88 B | ||
|
PetIQ
PETQ
|
64.9 | - | 1.64 % | $ 400 M | ||
|
Recro Pharma
REPH
|
49.1 | - | -4.76 % | $ 65.3 M | ||
|
OptiNose
OPTN
|
493 | - | - | $ 1.08 B | ||
|
PLx Pharma
PLXP
|
98.8 | - | -27.8 % | $ 2.56 M | ||
|
Viatris
VTRS
|
154 | $ 16.48 | 1.04 % | $ 19.2 B | ||
|
Zomedica Corp.
ZOM
|
187 | - | -0.21 % | $ 98 M | ||
|
Rockwell Medical
RMTI
|
29.2 | $ 0.62 | 0.35 % | $ 22.3 M | ||
|
China Pharma Holdings
CPHI
|
166 | $ 0.71 | -6.82 % | $ 3.05 M | ||
|
TherapeuticsMD
TXMD
|
1.04 K | $ 2.2 | 20.88 % | $ 25.5 M |